FDA.reportPublic FDA data

KYZATREX 150 MG Oral Capsule

RxCUI
2609607
RxNorm name
KYZATREX 150 MG Oral Capsule
Display name
KYZATREX 150 MG Oral Capsule
Full name
KYZATREX 150 MG Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7f7167a7-2a25-47e2-acf5-33f499fce971KYZATREX 150 MG Oral Capsule [PSN] · testosterone undecanoate 150 MG Oral Capsule [Kyzatrex] [SBD] · Kyzatrex 150 MG Oral Capsule [SY]322These highlights do not include all the information needed to use KYZATREX® safely and effectively. See full prescribing information for KYZATREX®. KYZATREX® (testosterone undecanoate) capsules, for oral use, CIII Initial U.S. approval: 195320251015